Highlights
COVID-19 patients have increased incidence of Epstein-Barr Virus reactivation.
Detection of EBV DNA is greater among COVID-19 positive patients (27.1% vs 12.5%).
No statistical difference in CRP levels of COVID-19 positive vs. negative patients.
No statistical difference in...
Saliva antibody-fingerprint of reactivated latent viruses after mild/asymptomatic COVID-19 is unique in patients with myalgic-encephalomyelitis/chronic fatigue syndrome
Eirini Apostolou, Muhammad Rizwan, Petros Moustardas, Per Sjögren, Bo Christer Bertilson, Björn Bragée, Olli Polo and Anders...
This site uses cookies to help personalise content, tailor your experience and to keep you logged in if you register.
By continuing to use this site, you are consenting to our use of cookies.